Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Atul Ltd (ATUL.NS)
Valsad, IN
Atul Ltd is a prominent global manufacturer and distributor, offering an extensive portfolio of chemical products. The company strategically organizes its operations across two primary divisions: Life Science Chemicals, and Performance and Other Chemicals. Its comprehensive product offerings encompass a vast array of compounds, including numerous aromatics such as cresol mixtures, allyl caproate, phenyl acetic acid, and anisyl alcohol. It also supplies a wide range of bulk chemicals and intermediates, including essential industrial materials like caustic soda lye, hydrochloric acid, sulphuric acid, hydrogen gas, resorcinol, and oleum. Further diversifying its output, Atul Ltd provides various colorants, a full suite of agrochemicals (such as fungicides, herbicides, and insecticides), and critical pharmaceutical building blocks, including amino acid derivatives, active pharmaceutical ingredients (APIs) and their intermediates, and phosgene derivatives. The company is also a key producer of epoxy-based solutions, offering resins, curing agents, reactive diluents, and catalysts. Beyond conventional chemicals, Atul Ltd is involved in the cultivation of tissue culture-raised oil and date palm plants. It also operates retail ventures focused on crop protection products and polymers. The versatility of Atul's products allows it to serve an exceptionally broad spectrum of industries worldwide. Its clientele spans sectors such as agriculture, automotive, pharmaceuticals, textiles, food and flavor, personal care, paints and coatings, construction, and electronics, among many others. Established in 1947, Atul Ltd has its corporate headquarters situated in Valsad, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.32% | -3.46% | -4.87% | +3.41% | +9.94% | +6.13% | -7.87% | -2.42% | -26.73% | +250.43% | +20,525.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 2 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | -1 |
-
Revenue growth Chemicals - Specialty: +4.7%+12.4% ★ Q1'26: +15.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+40.1% ★ Q1'26: +66.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+14.5% ★ Q1'26: +25.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+14.6% ★ Q1'26: +17.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.8% ★ Q1'26: +18.1% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.15× ★ Q1'26: 0.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 10 Rev. Ana. 10 EPS Ana. |
Mar 2027 11 Rev. Ana. 10 EPS Ana. |
Mar 2028 10 Rev. Ana. 10 EPS Ana. |
Mar 2029 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
26.56B
est: 27.08B (-1.9%)
|
25.95B
est: 26.17B (-0.8%)
|
28.34B
est: 28.50B (-0.6%)
|
32.96B
est: 32.58B (+1.2%)
|
40.38B
est: 40.58B (-0.5%)
|
40.93B
est: 40.34B (+1.5%)
|
37.31B
est: 37.39B (-0.2%)
|
50.81B
est: 50.06B (+1.5%)
|
54.28B
est: 55.87B (-2.9%)
|
47.26B
est: 47.69B (-0.9%)
|
55.83B
est: 55.93B (-0.2%)
|
62.70B
60.63B – 64.71B
+12.1% YoY
|
70.66B
66.46B – 79.21B
+12.7% YoY
|
77.22B
73.95B – 80.64B
+9.3% YoY
|
84.36B
80.09B – 91.19B
+9.2% YoY
|
| EBITDA |
3.95B
est: 4.73B (-16.6%)
|
4.61B
est: 3.69B (+25.1%)
|
5.15B
est: 5.10B (+1.1%)
|
5.06B
est: 6.16B (-17.8%)
|
7.68B
est: 6.58B (+16.7%)
|
9.03B
est: 8.71B (+3.7%)
|
9.18B
est: 9.53B (-3.7%)
|
9.15B
est: 11.22B (-18.4%)
|
8.10B
est: 12.00B (-32.5%)
|
6.35B
est: 13.21B (-51.9%)
|
9.17B
est: 8.91B (+2.9%)
|
9.93B
9.61B – 10.25B
+11.6% YoY
|
11.20B
10.53B – 12.55B
+12.7% YoY
|
12.24B
11.72B – 12.78B
+9.3% YoY
|
13.37B
12.69B – 14.45B
+9.2% YoY
|
| EBIT |
3.34B
est: 3.57B (-6.4%)
|
3.95B
est: 3.13B (+26.3%)
|
4.20B
est: 4.34B (-3.1%)
|
3.95B
est: 4.66B (-15.1%)
|
6.50B
est: 4.90B (+32.6%)
|
7.74B
est: 6.88B (+12.6%)
|
7.83B
est: 7.18B (+9.1%)
|
7.40B
est: 8.45B (-12.4%)
|
6.13B
est: 9.03B (-32.1%)
|
3.94B
est: 9.95B (-60.4%)
|
6.02B
est: 6.32B (-4.9%)
|
7.06B
6.82B – 7.28B
+11.6% YoY
|
7.95B
7.48B – 8.91B
+12.7% YoY
|
8.69B
8.32B – 9.07B
+9.3% YoY
|
9.49B
9.01B – 10.26B
+9.2% YoY
|
| Net Income |
2.41B
est: 2.35B (+2.5%)
|
2.74B
est: 2.27B (+20.9%)
|
3.23B
est: 3.00B (+7.5%)
|
2.76B
est: 3.66B (-24.5%)
|
4.32B
est: 3.43B (+26.1%)
|
6.66B
est: 4.56B (+46.2%)
|
6.56B
est: 6.17B (+6.3%)
|
6.04B
est: 7.26B (-16.8%)
|
5.14B
est: 7.77B (-33.8%)
|
3.23B
est: 8.55B (-62.2%)
|
4.84B
est: 4.91B (-1.4%)
|
6.24B
5.59B – 6.78B
+27.2% YoY
|
7.69B
6.95B – 8.81B
+23.1% YoY
|
9.46B
8.81B – 10.52B
+23.1% YoY
|
9.91B
9.26B – 10.96B
+4.7% YoY
|
| SGA |
1.67B
est: 2.11B (-20.6%)
|
1.95B
est: 1.94B (+0.8%)
|
2.05B
est: 2.40B (-14.6%)
|
2.17B
est: 2.67B (-18.9%)
|
2.63B
est: 1.72B (+53.2%)
|
3.08B
est: 1.82B (+68.6%)
|
3.13B
est: 3.07B (+2.0%)
|
3.44B
est: 3.61B (-4.6%)
|
3.75B
est: 3.86B (-2.9%)
|
4.06B
est: 4.25B (-4.6%)
|
4.61B
est: 4.85B (-5.1%)
|
5.38B
5.20B – 5.55B
+10.8% YoY
|
6.06B
5.70B – 6.79B
+12.7% YoY
|
6.62B
6.34B – 6.92B
+9.3% YoY
|
7.24B
6.87B – 7.82B
+9.2% YoY
|
| EPS |
81.13
est: 79.73 (+1.8%)
|
92.44
est: 104.25 (-11.3%)
|
108.88
est: 106.98 (+1.8%)
|
93.21
est: 109.72 (-15.0%)
|
145.72
est: 152.79 (-4.6%)
|
224.69
est: 223.12 (+0.7%)
|
221.17
est: 217.98 (+1.5%)
|
204.23
est: 226.39 (-9.8%)
|
174.15
est: 203.29 (-14.3%)
|
109.54
est: 147.78 (-25.9%)
|
164.37
est: 168.26 (-2.3%)
|
212.10
189.91 – 230.12
+26.1% YoY
|
261.16
235.94 – 299.08
+23.1% YoY
|
321.46
299.18 – 357.17
+23.1% YoY
|
336.70
314.57 – 372.18
+4.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-10 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-09 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-05 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-04 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-03 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-02 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-06-01 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.03% | 3.91M | 0.06% |
| 2 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.01% | 129.2K | 0.48% |
| 3 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.01% | 291.4K | 0.26% |
| 4 | Vanguard FTSE Emerging Markets ETF VWO | 0.01% | 14.38M | 0.06% |
| 5 | Vanguard ESG International Stock ETF VSGX | 0.00% | 204.2K | 0.10% |
| 6 | Vanguard Total International Stock ETF VXUS | 0.00% | 15.94M | 0.05% |
| 7 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 23.1K | 0.22% |
| 8 | Vanguard Total World Stock ETF VT | 0.00% | 721.6K | 0.06% |
| 9 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 69.6K | 0.22% |
| 10 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 37.4K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sunil Siddharth Lalbhai | Chairman & MD | 116M | male |
| Samvegbhai Arvindbhai-Lalbhai Sheth | MD, Promoter & Executive Director | 31M | male |
| Thirukonda R. Gopi Kannan | Chief Financial Officer & Whole Time Director | 24M | male |
| Lalit Patni | Company Secretary & Chief Compliance Officer | 9M | male |
| Vivek Gadre | Whole-time Director | 4M | male |
| Prabhakar Chebiyyam | President | — | male |
| Satish Jagannath Patil | President | — | male |
| Parasu Veera Uppara | President of Aromatics Business | — | — |
| Deepak Ahuja | Vice President of Human Resources | — | male |
| Ajitsingh Batra | Executive Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ATUL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
